Tumor Necrosis Factor Inhibition in the Acute Management of Traumatic Optic Neuropathy

PURPOSE: To determine the effectiveness of etanercept, a tumor necrosis factor (TNF) inhibitor, in conferring neuroprotection to retinal ganglion cells (RGCs) and improving visual outcomes after optic nerve trauma with either optic nerve crush (ONC) or sonication-induced traumatic optic neuropathy (...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Invest Ophthalmol Vis Sci
Prif Awduron: Tse, Brian C., Dvoriantchikova, Galina, Tao, Wensi, Gallo, Ryan A., Lee, John Y., Pappas, Steven, Brambilla, Roberta, Ivanov, Dmitry, Tse, David T., Pelaez, Daniel
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Association for Research in Vision and Ophthalmology 2018
Pynciau:
Eye Movements, Strabismus, Amblyopia and Neuro-Ophthalmology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5989875/
https://ncbi.nlm.nih.gov/pubmed/30025145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.18-24431
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg